Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (241-250 of 454) with videos related to

Pageof 46
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|November 29, 2015
Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on DialysisPatrick S Parfrey, Geoffrey A Block, Ricardo Correa-Rotter, et al.
Kidney International|December 5, 2020
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantationJolanta Małyszko, Aristotelis Bamias, Farhad R Danesh, et al.
The New England Journal of Medicine|October 27, 2018
Intravenous Iron in Patients Undergoing Maintenance HemodialysisIain C Macdougall, Claire White, Stefan D Anker, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 5, 2024
SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewSamuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Kidney International Supplements|January 25, 2019
Complications of chronic kidney disease: current state, knowledge gaps, and strategy for actionAminu K Bello, Mona Alrukhaimi, Gloria E Ashuntantang, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Kidney International|May 26, 2023
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceElaine Ku, Lucia Del Vecchio, Kai-Uwe Eckardt, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
Transplantation|May 31, 2003
New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003Jaime Davidson, Alan Wilkinson, Jacques Dantal, et al.
The Lancet. Diabetes & Endocrinology|September 10, 2019
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L Neuen, Tamara Young, Hiddo J L Heerspink, et al.
Pageof 46

Showing results (241-250 of 454) with videos related to

Sort By:
Pageof 46
Clinical Journal of the American Society of Nephrology : CJASN|November 29, 2015
Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on DialysisPatrick S Parfrey, Geoffrey A Block, Ricardo Correa-Rotter, et al.
Kidney International|December 5, 2020
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantationJolanta Małyszko, Aristotelis Bamias, Farhad R Danesh, et al.
The New England Journal of Medicine|October 27, 2018
Intravenous Iron in Patients Undergoing Maintenance HemodialysisIain C Macdougall, Claire White, Stefan D Anker, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 5, 2024
SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewSamuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Kidney International Supplements|January 25, 2019
Complications of chronic kidney disease: current state, knowledge gaps, and strategy for actionAminu K Bello, Mona Alrukhaimi, Gloria E Ashuntantang, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Kidney International|May 26, 2023
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceElaine Ku, Lucia Del Vecchio, Kai-Uwe Eckardt, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceJürgen Floege, Sean J Barbour, Daniel C Cattran, et al.
Transplantation|May 31, 2003
New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003Jaime Davidson, Alan Wilkinson, Jacques Dantal, et al.
The Lancet. Diabetes & Endocrinology|September 10, 2019
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L Neuen, Tamara Young, Hiddo J L Heerspink, et al.
Pageof 46